Bugianesi E - Search Results

1

Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort^☆" [J Hepatol (2020) 505-515].

Anstee QM, Darlay R, Cockell S, Meroni M, Govaere O, Tiniakos D, Burt AD, Bedossa P, Palmer J, Liu YL, Aithal GP, Allison M, Yki-Järvinen H, Vacca M, Dufour JF, Invernizzi P, Prati D, Ekstedt M, Kechagias S, Francque S, Petta S, Bugianesi E, Clement K, Ratziu V, Schattenberg JM, Valenti L, Day CP, Cordell HJ, Daly AK; EPoS Consortium Investigators. Anstee QM, et al. Among authors: bugianesi e. J Hepatol. 2023 May;78(5):1085-1086. doi: 10.1016/j.jhep.2023.02.028. Epub 2023 Mar 13. J Hepatol. 2023. PMID: 36922251 No abstract available.

2

Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.

Valenti L, Fracanzani AL, Dongiovanni P, Bugianesi E, Marchesini G, Manzini P, Vanni E, Fargion S. Valenti L, et al. Among authors: bugianesi e. Am J Gastroenterol. 2007 Jun;102(6):1251-8. doi: 10.1111/j.1572-0241.2007.01192.x. Epub 2007 Mar 27. Am J Gastroenterol. 2007. PMID: 17391316

3

Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability.

Ratziu V, Bugianesi E, Dixon J, Fassio E, Ekstedt M, Charlotte F, Kechagias S, Poynard T, Olsson R. Ratziu V, et al. Among authors: bugianesi e. Aliment Pharmacol Ther. 2007 Sep 15;26(6):821-30. doi: 10.1111/j.1365-2036.2007.03425.x. Aliment Pharmacol Ther. 2007. PMID: 17767466 Free article.

4

The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease.

Miele L, Beale G, Patman G, Nobili V, Leathart J, Grieco A, Abate M, Friedman SL, Narla G, Bugianesi E, Day CP, Reeves HL. Miele L, et al. Among authors: bugianesi e. Gastroenterology. 2008 Jul;135(1):282-291.e1. doi: 10.1053/j.gastro.2008.04.004. Epub 2008 Apr 11. Gastroenterology. 2008. PMID: 18515091 Free PMC article.

5

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.

Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, Bertelli C, Fatta E, Bignamini D, Marchesini G, Fargion S. Fracanzani AL, et al. Among authors: bugianesi e. Hepatology. 2008 Sep;48(3):792-8. doi: 10.1002/hep.22429. Hepatology. 2008. PMID: 18752331

6

HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.

Valenti L, Fracanzani AL, Bugianesi E, Dongiovanni P, Galmozzi E, Vanni E, Canavesi E, Lattuada E, Roviaro G, Marchesini G, Fargion S. Valenti L, et al. Among authors: bugianesi e. Gastroenterology. 2010 Mar;138(3):905-12. doi: 10.1053/j.gastro.2009.11.013. Epub 2009 Nov 18. Gastroenterology. 2010. PMID: 19931264 Free article.

7

From the metabolic syndrome to NAFLD or vice versa?

Vanni E, Bugianesi E, Kotronen A, De Minicis S, Yki-Järvinen H, Svegliati-Baroni G. Vanni E, et al. Among authors: bugianesi e. Dig Liver Dis. 2010 May;42(5):320-30. doi: 10.1016/j.dld.2010.01.016. Epub 2010 Mar 6. Dig Liver Dis. 2010. PMID: 20207596 Free article. Review.

8

Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.

Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P, Nobili V, Mozzi E, Roviaro G, Vanni E, Bugianesi E, Maggioni M, Fracanzani AL, Fargion S, Day CP. Valenti L, et al. Among authors: bugianesi e. Hepatology. 2010 Apr;51(4):1209-17. doi: 10.1002/hep.23622. Hepatology. 2010. PMID: 20373368

9

Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling--a propensity score-adjusted observational study.

Valenti L, Moscatiello S, Vanni E, Fracanzani AL, Bugianesi E, Fargion S, Marchesini G. Valenti L, et al. Among authors: bugianesi e. QJM. 2011 Feb;104(2):141-9. doi: 10.1093/qjmed/hcq170. Epub 2010 Sep 17. QJM. 2011. PMID: 20851820 Clinical Trial.

10

Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.

Fracanzani AL, Valenti L, Bugianesi E, Vanni E, Grieco A, Miele L, Consonni D, Fatta E, Lombardi R, Marchesini G, Fargion S. Fracanzani AL, et al. Among authors: bugianesi e. J Hepatol. 2011 Jun;54(6):1244-9. doi: 10.1016/j.jhep.2010.09.037. Epub 2010 Nov 11. J Hepatol. 2011. PMID: 21145841 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

338 results

Search Page

Filters